• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • DONATE
  • Pay 2023 Membership Dues
  • Join PeDRA
  • Login
MENUMENU
  • Contact Us
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Community Spotlight
        • Play Eczema Counts Now!
        • Patient Advisory Committee
        • Find a Pediatric Dermatologist (from SPD)
        • Parents, advocates, and patients over the age of 18 with a direct connection or significant interest in childhood skin disease or pediatric dermatology research are encouraged to join the PeDRA network for free as Community Members.

          Apply Now!

  • Education and Events
        • Virtual Education
        • PeDRA Podcasts
        • Points of Discussion Podcast
        • Mentorship Program
        • SPD/PeDRA Journal Club
        • 2022 PeDRA Annual Conference
        • Dash for Discovery Fun Run/Walk
        • Early Investigator Support
        • Play Eczema Counts Now!
        • Events Calendar
        • Save the Date! The 2023 PeDRA Annual Conference will be held November 9-11, 2023 at the Westin Buckhead Atlanta in Atlanta, GA.

           

          Listen to PeDRA’s newest podcast series, Industry 101!

  • Research
        • Grants and Fellowships
        • Resources for Researchers
        • Survey Application
        • Study Application
        • Research Areas
        • Publications
        • Now accepting applications for the Emerging Investigator Research Grants Program and Research Fellowships Program.

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports & Financials
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • 2022 marked PeDRA’s 10th year of pursuing the vision of changing lives and healing children with skin disease through collaboration and discovery. Visit our 10th Anniversary Page to learn more about the origin of PeDRA and the many accomplishments during the first ten years!

  • Member Login

Hair Disorders

Alopecia & Us: studying the impact of alopecia areata to adolescents and the family

January 17, 2023 By Katherine Devenport


Principal Investigator:

Chantal Cotter, MD
St. John’s Institute of Dermatology

Overview:

Alopecia areata (AA) is one of the most common hair loss disorders characterized by loss of hair in round patches, usually on the scalp. The exact cause of AA is unknown, but it seems to be caused by the immune system attacking the hair follicles by mistake. Having AA can have impact on a child’s sense of well-being and increase their risk of mental health disorders including depression, anxiety, and OCD. Further, there may an impact on the family’s quality of life. Understanding this burden is paramount to ensuring we understand the full effect AA has on a child. We will do this via an online questionnaire which patients (aged 12-18) and their families can complete at home, anytime, anywhere in the world and in any language. Only through awareness of the full impact of this disease we will be able to advocate for access to treatments but also campaign for recognition and support of mental health in this group.

Status:

This project was funded by a 2022 Pediatric Alopecia Areata Challenge Grant.

Filed Under: Hair Disorders

Pediatric and Adolescent Vitiligo Guidelines

April 6, 2022 By Katherine Devenport


Project Lead:

Nanette Silverberg, MD
Icahn School of Medicine at Mount Sinai

Overview:

People with vitiligo lose their color progressively over time, in locations easily seen like faces and hands. Half of the vitiligo cases start by age 20, one-quarter by age 10 years, making this one of the most common pediatric skin conditions. Children with vitiligo get teased, bullied, and become self-conscious. There are no specific guidelines for the care of pediatric vitiligo. We will gather as experts in pediatric vitiligo to critically review published evidence and make informed recommendations to guide the care of children with vitiligo.

Status:

This project was funded through a 2021 PeDRA Consensus Grant.

Filed Under: Hair Disorders

Assessment of hearing and vision in pediatric vitiligo patients

April 6, 2022 By Katherine Devenport


Principal Investigator:

Anna Garza-Mayers, MD, PhD
University of Massachusetts Chan Medical School

Overview:

Vitiligo is a common skin disorder in which the body’s own immune cells attack melanocytes, the cells that produce pigment in the skin, resulting in white spots. Melanocytes also exist in other organs of the body, including the ears and eyes, and some research suggests melanocyte destruction may also affect hearing and vision. Using routine screening tests, our study will compare hearing and vision in pediatric patients with and without vitiligo to determine whether children with vitiligo are at increased risk for hearing loss and decreased vision. This could lead to larger studies and could affect if and how often children with vitiligo are referred for screening tests, potentially impacting their development and quality of life.

Status:

This project was funded by a 2021 PeDRA Research Grant.

Filed Under: Hair Disorders

Needle-free delivery of intralesional triamcinolone for pediatric alopecia areata: a pilot study of patient tolerability

April 6, 2022 By Katherine Devenport


Principal Investigator:

Sonal Shah, MD
University Hospitals Cleveland Medical Center
Case Western Reserve University

Overview:

Alopecia areata (AA) is a type of hair loss that affects both adults and children. It may be limited to a few spots on the scalp or lead to hair loss across the whole body. AA has often been inappropriately considered a cosmetic condition; however, it can cause significant emotional and psychosocial distress. This can negatively impact the quality of life in affected children. Currently, there are no FDA-approved treatments for this disease. However, we do know that injecting steroids into the areas of hair loss can lead to regrowth. Unfortunately, the use of needles can be scary and painful for children, and many are unable to tolerate this treatment option. We aim to study the tolerability and effectiveness of a novel medical device that can deliver medication into the skin without the use of a needle.

Status:

This project was funded by a 2021 PeDRA Research Grant.

Filed Under: Hair Disorders

Footer

  • Our Membership
  • For Patients
  • For Researchers
  • Governance Policies
  • Financial Conflict of Interest Policy
  • Jobs at PeDRA
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Sign up to receive emails from PeDRA
Join PeDRA
Donate

Copyright © 2023 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy